2
1
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T10171 |
5-Hydroxypyrazine-2-Carboxylic Acid
|
Others | Others |
5-Hydroxypyrazine-2-Carboxylic Acid is a metabolite of anti-tuberculosis drug pyrazinamide. | |||
T37880 |
OPC-167832
|
||
OPC-167832 is a potent and orally active dprE1 Inhibitor with an IC50 of 0.258 μM. OPC-167832 has antituberculosis activity and can be used for the research of tuberculosis caused by Mycobacterium tuberculosis[1]. OPC-167832 exhibits very low MICs against laboratory strains of M. tuberculosis H37Rv (MIC: 0.0005 μg/ml) and Kurono (MIC: 0.0005 μg/ml) and strains with monoresistance to rifampin (RIF), isoniazid (INH), ethambutol (EMB), streptomycin (STR), and pyrazinamide (PZA) (MIC: 0.00024-0.001 ... |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T1426 |
Pyrazinamide
Pyrazinoic acid amide,Pyrazinecarboxamide,吡嗪酰胺 |
Antibacterial; Antibiotic; Autophagy; Fatty Acid Synthase | Autophagy; Metabolism; Microbiology/Virology |
Pyrazinamide (Pyrazinecarboxamide) 是一种口服抗结核类抗生素。它是一种前药,通过结核分枝杆菌pncA 基因编码的 PZase/烟酰胺酶转化为活性吡嗪酸形式。 |